Key Insights

Highlights

Success Rate

84% trial completion

Published Results

19 trials with published results (10%)

Research Maturity

56 completed trials (29% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.8%

11 terminated out of 190 trials

Success Rate

83.6%

-3.0% vs benchmark

Late-Stage Pipeline

14%

27 trials in Phase 3/4

Results Transparency

34%

19 of 56 completed with results

Key Signals

19 with results84% success11 terminated

Data Visualizations

Phase Distribution

128Total
Not Applicable (42)
Early P 1 (5)
P 1 (29)
P 2 (25)
P 3 (10)
P 4 (17)

Trial Status

Recruiting70
Completed56
Not Yet Recruiting39
Terminated11
Unknown5
Active Not Recruiting4

Trial Success Rate

83.6%

Benchmark: 86.5%

Based on 56 completed trials

Clinical Trials (190)

Showing 20 of 20 trials
NCT07740200CompletedPrimary

Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic Study

NCT06991114Phase 2Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT07737119Not ApplicableCompletedPrimary

Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid Arthritis

NCT07564154Phase 1RecruitingPrimary

A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)

NCT07730723Phase 2Not Yet RecruitingPrimary

The Effect of Nicorandil on Rheumatoid Arthritis Patients

NCT07729995Phase 1Not Yet RecruitingPrimary

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

NCT06706999Not ApplicableCompletedPrimary

Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

NCT07721142Phase 4RecruitingPrimary

Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis

NCT03631225CompletedPrimary

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

NCT07401732RecruitingPrimary

Dysphagia in Rheumatoid Arthritis

NCT07484243RecruitingPrimary

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

NCT07087912Phase 4RecruitingPrimary

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

NCT07709312Phase 2Not Yet RecruitingPrimary

the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients

NCT07315997RecruitingPrimary

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

NCT07684157Phase 2Not Yet RecruitingPrimary

A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis

NCT07678112Not ApplicableRecruitingPrimary

Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy

NCT07675226Phase 1Not Yet Recruiting

Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions

NCT07473154Phase 1Recruiting

Controlling Hyperactive Immunity With Long-lived Lymphocytes

NCT07277491Completed

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

NCT07674134RecruitingPrimary

Comparison of Oral Administration of a JAK Inhibitor in Rheumatoid Arthritis

Scroll to load more

Research Network

Activity Timeline